• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

Technologies.org

Technology Trends: Follow the Money

  • Technology Events 2023-2024
  • Sponsored Post
    • Make a Contribution
  • Technology Markets
    • Venture Capital
  • About
  • Contact

Genomic Vision Announces a Strategic Partnership With GIPTIS (Genetics Institute for Patients, Therapies, Innovation & Science) Focusing on the Fight Against Genetic Diseases

January 15, 2020 By admin Leave a Comment

GENOMIC VISION (Paris:GV) (FR0011799907 – GV), a biotechnology company developing Molecular and Artificial Intelligence tools to investigate DNA structural and dynamic changes, in particular in the human genome, is pleased to announce a partnership with GIPTIS, the future Euro Mediterranean Institute founded by Professor Nicolas Lévy, head of the Medical Genetic Department at the renowned hospital of “La Timone” in Marseille. The aim of this partnership is to accelerate and facilitate the diagnosis and treatment of patients, thanks to Genomic Vision proprietary technology and expertise.

In order to improve the management of patients affected by rare genetic diseases, GIPTIS has defined as main objectives to accelerate diagnosis, increase research capacity, multiply the number of effective treatments and improve the care of patients and families.

Professor Nicolas Lévy explains: “Genomic Vision has developed a powerful technology that helps to understand complex genetic abnormalities, in particular in aging and neurological diseases, two therapeutic areas with high unmet clinical needs. It is really helpful in particular to characterize genomic regions with highly repeated sequences for which NGS technologies are not efficient enough.”

Terms of the partnership include several research programs with the development of news assays targeting specific genetic disorders on which Genomic Vision will have exclusive commercialization rights.

Aaron Bensimon, CEO and co-founder of Genomic Vision, adds: “It is the fusion between technological innovation and unmet clinical needs that will cross the frontiers and will bring to the doctors and patients novel tests. Genomic Vision and GIPTIS are the appropriate partners to develop such a novel approach. GIPTIS will bring to GV an important source of unmet medical need in the field of neurological diseases and will be a major asset for the development and validation of these new tests. We are very proud to have been selected by this prestigious institute to participate in this outstanding project. It is not only an opportunity to set-up new IVD assays, but also an opening to Southern markets in which genetic disease rates are higher than elsewhere.”

ABOUT GIPTIS
Today, rare genetic diseases affect 3 million people in France, more than cancer and Alzheimer’s disease combined, and 50 million around the Mediterranean. More than 95% of patients are without adequate treatment and 60% of them are children.

In the majority of cases, these diseases are serious, disabling, chronic and have an impact on entire families.

The aim of GIPTIS: to treat patients better, faster and on a larger scale by facilitating collaborations between the best of the public and private sectors, academic and industrial worlds. GIPTIS unites medical teams, fundamental and applied research teams, start-ups, drug companies and patients associations in the same innovative place of excellence.

GIPTIS faces 4 challenges: accelerate the diagnoses, increase research capacity, multiply the number of effective treatments, improve care for patients and families.

Founded by internationally acclaimed geneticist, Professor Nicolas Lévy, GIPTIS will be a non-profit foundation with mixed governance, for successful cooperation between private and public sectors.

ABOUT GENOMIC VISION
GENOMIC VISION is a biotechnology company developing molecular assays and Artificial Intelligence tools to control quality and safety of genetically modified genomes, in particular in genome editing technologies and biomanufacturing processes. These tools are currently use for monitoring DNA replication in cancerous cell, for early cancer detection and the diagnosis of genetic diseases. Based near Paris, in Bagneux, the Company has approximately 30 employees. GENOMIC VISION is a public listed company listed in compartment C of Euronext’s regulated market in Paris (Euronext: GV – ISIN: FR0011799907).

For further information, please visit www.genomicvision.com.

Membre des indices CAC® Mid & Small et CAC® All-Tradable

Filed Under: Tech Tagged With: genome editing technologies

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Market Analysis

How to discover the treasure trove of hidden marketing insights by watching customer behavior
Navigating Uncertainty: Prioritizing Hydrogen R&D Efforts for a Sustainable Future
Unleashing the Hidden Talent Pool: The Rise of STARs – Skilled Through Alternative Routes
United Against China: Japan and the Netherlands to Join US in Restricting Semiconductor Exports
Revolutionizing Agriculture: How CRISPR is Changing the Game
The ticking time bomb: Understanding the demographic challenges facing our planet
Smart logistics market to reach $14 billion by 2024

Market Research Media

Turn Your Story into a Game: The Art of Gamifying Your Plot
The end of cheap money is redrawing the map of corporate earnings
The Future of Virtual Reality: How VR is Changing Industries
Market Research Media Survey: The State of Streaming Services
Media measurement services provide a holistic view of cross-media consumption
Gen Z ranks top in luxury sales
How to market recycled products

Secondary Sidebar

Tech Events

Chiplet Summit, January 24-26 2023, the Doubletree by Hilton San Jose Hotel
Flagship Community Conference for the Leading Open Source Browser Automation Standard Returns to In-person Event in Chicago, March 28-30, 2023
The 2nd annual Connecting Green Hydrogen Europe 2023 will Take Place 5th – 6th July 2023 at Riu Plaza España Madrid, Spain
DesignCon, the nation’s must-attend event for chip, board and systems design engineers, Jan. 31- Feb. 2 2023, Santa Clara Convention Center
Chiplet Summit, January 24-26, 2023, Doubletree by Hilton, San Jose

Venture Capital

The Importance of Diversity and Inclusion in the Workplace
Sequoia Capital announces its $195 Mln dedicated seed fund
Sublime Systems Secures $40 Million Series A to Electrify and Scale Decarbonized Cement Production
actyv.ai Raises Pre-Series A Funding to Fuel Global Expansion, Product Enhancement
Ottopia announces $14.5M Series A Funding Round

Footer

Recent Posts

  • The Evolution of the Skateboard
  • How can we clean space junk?
  • How Electric Vehicles (EV) Are Changing the Automotive Industry
  • Scientists are looking for intelligent alien life
  • The Rise of Quantum Computing: Understanding the Basics and its Potential Impact
  • The Future of Automation: How Robotics and Artificial Intelligence are Changing the Landscape of Industry
  • The Rise of Edge Computing: How It’s Changing the Way We Process Data
  • The Future of Virtual Reality: A Look at the Latest Developments
  • Tech Summit 2023 has been a huge success
  • Recession kills investments in moonshot R&D and startups

App Coding

Configit Introduces Breakthrough System-Level Configuration Solution
Digital twins transform the efficiency of current business processes
monday.com Adds Built-In Monetization Solution to the apps marketplace
Ondat 2.8 Arrives in GA with Increased Support for Stateful Workloads in Kubernetes
Coder Announces First Multi-Cloud, Multi-Compute Integrated Development Environment Platform

API Coding

How to code an API with ChatGPT
Profound Logic Builds IBM i Salesforce API Integration Example without Writing a Single Line of Code
Most commonly used HTTP Headers
How to recognize malware API
What is a REST API?

Blockchaining

Blockchain technology and carbon credits
Asia’s Premier Web3 Conference TOKEN2049 Returns to Singapore in September 2023
Highlights: Blockchain Conference in Tel Aviv
Blockchain Technology: Ownership Through Equity Tokenization
State of Technology Overview: Blockchaining 2023

Event Calendar

NAHB International Builders’ Show (IBS 2023) in Las Vegas from January 31 to February 2, 2023
India’s largest biennial automobile exhibition Auto Expo 2023 held on January 12-15, 2023 at Pragati Maidan, New Delhi
NRF 2023, Retail’s Big Show and Expo, January 15 to 17, 2023, Jacob K. Javits Center, New York
DOMOTEX Hannover 2023′ in Germany from 12-15 January
Electrify Expo Austin Set to Be Largest EV Demo Event of the 2022 Season, November 12-13, 2022, Austin, Texas

Copyright © 2022 Technologies.org

Media Partners: Market Analysis & Market Research and Exclusive Domains

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT